EUVIMEDDescoperă EUVIMED
Open access

Epigenetic Signature of the Metastable Epiallele VTRNA2‐1 : Adipose Dysfunction and Suboptimal Bariatric Outcomes

Yi-Chun Huang iD, Kuan-Jung Hou, Ming-Lung Tsai, Keng-Hao Liu, Ming-Yun Ho, Jih-Kai Yeh iD, Chun-Chi Chen, Chin-Yuan Chia, Wen-Lang Fan, I-Chang Hsieh, Ta-Sen Ye, Horng-Dar Wang and 2 more

Obesity · 2026

DOI: 10.1002/oby.70268 ↗

At a glance

Journal article in Obesity, 2026. Written by Yi-Chun Huang and 13 co-authors. Institution: Division of Cardiology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan City, Taiwan. Major MEDLINE topics: Bariatric Surgery, Epigenesis, Genetic, DNA Methylation, Adipose Tissue. 21 references. The full text is freely available in PubMed Central. Funded by: National Health Research Institutes, National Science and Technology Council, Chang Gung Memorial Hospital.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Objective

VTRNA2‐1 is a metastable epiallele whose methylation is associated with metabolic homeostasis via PKR‐mediated inflammation and adipocyte function. We aimed to determine whether preoperative VTRNA2‐1 promoter methylation in peripheral blood predicts long‐term excess weight loss (%EWL) after bariatric surgery. We explored transcriptional signatures in adipose tissue to clarify the relationship between early‐life epigenetic imprinting on adult metabolic plasticity and surgical outcomes in patients with severe obesity.

Methods

In the OCEAN prospective registry (2011–2024), 179 adults underwent bariatric surgery. Peripheral blood DNA VTRNA2‐1 methylation was classified as hypo‐, intermediate, or hyper‐methylated. %EWL was recorded at 3, 6, 12, and 24 months. Adipose tissue was assayed for IL13 , PRDM16 , and related transcripts.

Results

VTRNA2‐1 methylation showed a bimodal distribution, differing significantly from controls ( p = 0.002). Hypermethylated patients had lower VTRNA2‐1 expression ( p < 0.001) and greater %EWL at 12 (67.8% ± 19.1% vs. 61.8% ± 17.5%; p = 0.047) and 24 months (68.7% ± 21.9% vs. 60.4% ± 19.3%; p = 0.040). The hypomethylated group maintained a stable weight loss plateau between 12 and 24 months. Hypomethylation was associated with nominally higher IL13 and PRDM16 mRNA in adipose tissue (exploratory; uncorrected p < 0.05).

Conclusions

VTRNA2‐1 methylation status is associated with predictable variations and offers potential for preoperative risk stratification and personalized therapeutic strategies in managing severe obesity.

Subjects

MeSH terms (MEDLINE)

Bariatric SurgeryEpigenesis, GeneticDNA MethylationAdipose TissueObesity, MorbidHumansFemaleWeight LossAdultMaleMiddle AgedProspective StudiesPromoter Regions, GeneticTranscription FactorsDNA-Binding ProteinsTreatment Outcome

Substances

Transcription FactorsDNA-Binding ProteinsPRDM16 protein, human

Authors and institutions

  • Division of Cardiology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan City, Taiwan.
  • School of Medicine, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
  • Division of Cardiology, New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan.
  • College of Management, Chang Gung University, Taoyuan City, Taiwan.
  • Department of General Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan City, Taiwan.
  • Department of Medical Research, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

ORCID profiles: Yi-Chun Huang, Jih-Kai Yeh

Funding

  • National Health Research Institutes
  • National Science and Technology Council
  • Chang Gung Memorial Hospital
  • Chang Gung Memorial Hospital-National Tsing Hua University Joint Research Program

Cite

APA

Huang, Y. C., Hou, K. J., Tsai, M. L., Liu, K. H., Ho, M. Y., Yeh, J. K., Chen, C. C., Chia, C. Y., Fan, W. L., Hsieh, I. C., Ye, T. S., Wang, H. D., Tsai, C. N., & Wang, C. Y. (2026). Epigenetic Signature of the Metastable Epiallele VTRNA2‐1 : Adipose Dysfunction and Suboptimal Bariatric Outcomes. Obesity. https://doi.org/10.1002/oby.70268

Vancouver

Huang YC, Hou KJ, Tsai ML, Liu KH, Ho MY, Yeh JK, et al. Epigenetic Signature of the Metastable Epiallele VTRNA2‐1 : Adipose Dysfunction and Suboptimal Bariatric Outcomes. Obesity. 2026. doi:10.1002/oby.70268

BibTeX
@article{Huang2026,
  author = {Huang, Yi-Chun and Hou, Kuan-Jung and Tsai, Ming-Lung and Liu, Keng-Hao and Ho, Ming-Yun and Yeh, Jih-Kai and Chen, Chun-Chi and Chia, Chin-Yuan and Fan, Wen-Lang and Hsieh, I-Chang and Ye, Ta-Sen and Wang, Horng-Dar and Tsai, Chi-Neu and Wang, Chao-Yung},
  title = {Epigenetic Signature of the Metastable Epiallele VTRNA2‐1 : Adipose Dysfunction and Suboptimal Bariatric Outcomes},
  journal = {Obesity},
  year = {2026},
  doi = {10.1002/oby.70268}
}
Start for free →